United States Biotechnology & Medical Research

Lixte Biotechnology Holdings Inc (LIXT)

Track

Lixte Biotechnology Holdings Inc has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on October 3, 2023, when the President and CEO purchased shares. Prior to this, various executives and insiders engaged in multiple buy transactions throughout late 2022.
Ticker: LIXT Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lixte Biotechnology Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.8
van der Baan Bastiaan Jeroen President and CEO Executive Director
Transaction date
Purchase
Price
452.20
Quantity 37,939 +43.6%
Value US$1,019,665
0.8
van der Baan Bastiaan Jeroen Non-Executive Director
Transaction date
Purchase
Price
390.08
Quantity 14,771 -18.2%
Value US$4,387,822
3.0
Bernards Rene Non-Executive Director
Transaction date
Purchase
Price
433.57
Quantity 9,834 +34.0%
Value US$2,552,631
3.0
Bernards Rene Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 10,000 +8.0%
Value US$6,100
2.7
FORMAN ERIC Vice President and COO Officer
Transaction date
Purchase
Price
0.56
Quantity 2,484 +2.5%
Value US$1,391
2.7
FORMAN ERIC Vice President and COO Officer
Transaction date
Purchase
Price
0.56
Quantity 1,457 +1.5%
Value US$816
2.4
Brown Regina Non-Executive Director
Transaction date
Purchase
Price
0.58
Quantity 2,600 +70.3%
Value US$1,508
2.4
Brown Regina Non-Executive Director
Transaction date
Purchase
Price
0.57
Quantity 2,400 +184.6%
Value US$1,368
2.7
FORMAN ERIC Vice President and COO Officer
Transaction date
Purchase
Price
0.56
Quantity 6,059 +6.6%
Value US$3,389
2.7
FORMAN ERIC Vice President and COO Officer
Transaction date
Purchase
Price
0.56
Quantity 2,500 +2.8%
Value US$1,400
2.7
FORMAN ERIC Vice President and COO Officer
Transaction date
Purchase
Price
0.57
Quantity 7,648 +9.3%
Value US$4,336
2.7
FORMAN ERIC Vice President and COO Officer
Transaction date
Purchase
Price
0.54
Quantity 4,852 +6.3%
Value US$2,619
3.0
Bernards Rene Non-Executive Director
Transaction date
Purchase
Price
0.53
Quantity 52,500 +72.4%
Value US$27,825
Schwartzberg Gil Large shareholder
Transaction date
Purchase
Price
4.75
Quantity 105,264 +73.9%
Value US$500,004
Yen Yun Non-Executive Director
Transaction date
Purchase
Price
4.75
Quantity 52,632 +inf%
Value US$250,002
2.6
GREENBERG ROBERT Large shareholder
Transaction date
Purchase
Price
4.75
Quantity 52,632 +5.6%
Value US$250,002
Forman Stephen J. Non-Executive Director
Transaction date
Purchase
Price
4.75
Quantity 21,053 +126.3%
Value US$100,002
Palmedo Philip F Non-Executive Director
Transaction date
Purchase
Price
4.75
Quantity 21,053 +191.3%
Value US$100,002
Kovach John S President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
4.75
Quantity 21,100 +1.4%
Value US$100,225
Schwartzberg Gil Large shareholder
Transaction date
Purchase
Price
0.50
Quantity 1,040,000 +121.6%
Value US$520,000
Riggs Arthur Large shareholder
Transaction date
Purchase
Price
0.50
Quantity 1,260,000 +26.0%
Value US$630,000
Forman Stephen J. Non-Executive Director
Transaction date
Purchase
Price
0.50
Quantity 100,000 +inf%
Value US$50,000
Palmedo Philip F Non-Executive Director
Transaction date
Purchase
Price
0.50
Quantity 100,000 +10.0%
Value US$50,000
Schwartzberg Gil Large shareholder
Transaction date
Purchase
Price
0.06
Quantity 1,005,556 +12.4%
Value US$59,328
FORMAN ERIC Large shareholder
Transaction date
Purchase
Price
0.30
Quantity 10,000 +11.1%
Value US$3,000
FORMAN ERIC Large shareholder
Transaction date
Purchase
Price
0.30
Quantity 43,500 +93.5%
Value US$12,963
FORMAN ERIC Large shareholder
Transaction date
Purchase
Price
0.25
Quantity 2,500 +5.7%
Value US$625
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-05 2023-10-03 B Purchase
0.8
van der Baan Bastiaan Jeroen

President and CEO

Executive Director
37,939 +43.6%
452.20
US$1,019,665 		37,939 +43.6% 452.20 US$1,019,665
2023-01-04 2022-12-30 B Purchase
0.8
van der Baan Bastiaan Jeroen
Non-Executive Director
14,771 -18.2%
390.08
US$4,387,822 		14,771 -18.2% 390.08 US$4,387,822
2022-12-16 2022-12-15 B Purchase
3.0
Bernards Rene
Non-Executive Director
9,834 +34.0%
433.57
US$2,552,631 		9,834 +34.0% 433.57 US$2,552,631
2022-12-13 2022-12-12 B Purchase
3.0
Bernards Rene
Non-Executive Director
10,000 +8.0%
0.61
US$6,100 		10,000 +8.0% 0.61 US$6,100
2022-11-23 2022-11-22 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
2,484 +2.5%
0.56
US$1,391 		2,484 +2.5% 0.56 US$1,391
2022-11-23 2022-11-21 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
1,457 +1.5%
0.56
US$816 		1,457 +1.5% 0.56 US$816
2022-11-22 2022-11-21 B Purchase
2.4
Brown Regina
Non-Executive Director
2,600 +70.3%
0.58
US$1,508 		2,600 +70.3% 0.58 US$1,508
2022-11-22 2022-11-21 B Purchase
2.4
Brown Regina
Non-Executive Director
2,400 +184.6%
0.57
US$1,368 		2,400 +184.6% 0.57 US$1,368
2022-11-21 2022-11-18 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
6,059 +6.6%
0.56
US$3,389 		6,059 +6.6% 0.56 US$3,389
2022-11-21 2022-11-18 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
2,500 +2.8%
0.56
US$1,400 		2,500 +2.8% 0.56 US$1,400
2022-11-21 2022-11-18 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
7,648 +9.3%
0.57
US$4,336 		7,648 +9.3% 0.57 US$4,336
2022-11-21 2022-11-17 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
4,852 +6.3%
0.54
US$2,619 		4,852 +6.3% 0.54 US$2,619
2022-11-15 2022-11-14 B Purchase
3.0
Bernards Rene
Non-Executive Director
52,500 +72.4%
0.53
US$27,825 		52,500 +72.4% 0.53 US$27,825
2020-12-07 2020-11-30 B Purchase
Schwartzberg Gil
Large shareholder
105,264 +73.9%
4.75
US$500,004 		105,264 +73.9% 4.75 US$500,004
2020-12-04 2020-11-30 B Purchase
Yen Yun
Non-Executive Director
52,632 +inf%
4.75
US$250,002 		52,632 +inf% 4.75 US$250,002
2020-12-03 2020-11-30 B Purchase
2.6
GREENBERG ROBERT
Large shareholder
52,632 +5.6%
4.75
US$250,002 		52,632 +5.6% 4.75 US$250,002
2020-12-03 2020-11-30 B Purchase
Forman Stephen J.
Non-Executive Director
21,053 +126.3%
4.75
US$100,002 		21,053 +126.3% 4.75 US$100,002
2020-12-03 2020-11-30 B Purchase
Palmedo Philip F
Non-Executive Director
21,053 +191.3%
4.75
US$100,002 		21,053 +191.3% 4.75 US$100,002
2020-12-02 2020-11-30 B Purchase
Kovach John S

President and CEO

Executive Director Large shareholder
21,100 +1.4%
4.75
US$100,225 		21,100 +1.4% 4.75 US$100,225
2018-12-11 2018-12-07 B Purchase Schwartzberg Gil Large shareholder
1,040,000 +121.6%
0.50
US$520,000 		1,040,000 +121.6% 0.50 US$520,000
2018-12-11 2018-12-07 B Purchase Riggs Arthur Large shareholder
1,260,000 +26.0%
0.50
US$630,000 		1,260,000 +26.0% 0.50 US$630,000
2018-12-11 2018-12-07 B Purchase Forman Stephen J. Non-Executive Director
100,000 +inf%
0.50
US$50,000 		100,000 +inf% 0.50 US$50,000
2018-12-11 2018-12-07 B Purchase Palmedo Philip F Non-Executive Director
100,000 +10.0%
0.50
US$50,000 		100,000 +10.0% 0.50 US$50,000
2017-01-12 2017-01-11 B Purchase Schwartzberg Gil Large shareholder
1,005,556 +12.4%
0.06
US$59,328 		1,005,556 +12.4% 0.06 US$59,328
2016-02-19 2016-02-19 B Purchase FORMAN ERIC Large shareholder
10,000 +11.1%
0.30
US$3,000 		10,000 +11.1% 0.30 US$3,000
2016-02-19 2016-02-17 B Purchase FORMAN ERIC Large shareholder
43,500 +93.5%
0.30
US$12,963 		43,500 +93.5% 0.30 US$12,963
2016-02-04 2016-02-04 B Purchase FORMAN ERIC Large shareholder
2,500 +5.7%
0.25
US$625 		2,500 +5.7% 0.25 US$625
Explore more

More insider trading research around Lixte Biotechnology Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America